![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 32, 22464-22468, August 6, 1999
From the As type IX collagen is a minor cartilage
component, it is difficult to purify sufficient amounts of it from
tissues or cultured cells to study its structure and function. Also,
the conventional pepsin digestion used for fibrillar collagens cannot
be utilized for purifying type IX collagen, because it contains several
interruptions in its collagenous triple helix. A baculovirus expression
system was used here to produce recombinant human type IX collagen by coinfecting insect cells with three viruses containing full-length cDNAs for the Type IX collagen, which belongs to the group of fibril-associated
collagens with interrupted triple helices, is a component of hyaline
cartilage, intervertebral discs, and the vitreous body. The molecule is
a heterotrimer consisting of three genetically distinct chains,
Hyaline cartilage contains mixed fibrils of types II, IX, and XI
collagens, of which type II is the major component. Type XI collagen is
an internal component of the fibril, whereas type IX collagen is
located on the surface. Covalent lysine-derived cross-links between the
central COL2 region of the The association of The factors responsible for chain selection and assembly in the case of
the fibril-associated collagens with interrupted triple helices are
likely to be different from those affecting the fibrillar collagens,
because their C-terminal NC1 domains are much smaller and there is no
appreciable homology with the C-propeptides of the fibrillar collagens.
The chain assembly of type IX collagen has been studied both in
vitro and in vivo. Labourdette and van der Rest (14)
carried out chain association experiments in vitro using the
polypeptide components of a pepsin-resistant low molecular weight
fragment (15) isolated from bovine cartilage and showed that
homotrimers can be formed, especially by the In the present work, we have used a baculovirus expression system to
produce recombinant human type IX collagen in insect cells in order to
study the structure and chain assembly of type IX collagen. We report
here for the first time on the production of type IX collagen, which
consists of three different Construction of Full-length cDNAs for Type IX Collagen Expression of Recombinant Type IX Collagen--
Sf9 or
Trichoplusia ni (High Five; Invitrogen) insect cells were
cultured in monolayers in TNM-FH medium (Sigma) supplemented with 10%
fetal bovine serum (Bioclear), and High Five cells were also cultured
in suspension in Sf-900 II SFM medium (Life Technologies, Inc.)
supplemented with 5% fetal bovine serum at 27 °C. Prior to the
infection, the insect cells were seeded at densities of 5-6 × 105 cells/ml for the expression of recombinant proteins in
monolayers and 1 × 106 cells/ml for expression in
suspension. The cells were co-infected with three viruses coding for
the Isolation of Recombinant Type IX Collagen from Insect
Cells--
After 72 h of infection, the High Five cells were
detached from the culture plates by pipetting and harvested by
centrifugation at 1000 × g for 5 min. Those cultured
in suspension were also harvested by centrifugation. Intracellular
proteins were extracted from the cells by homogenization in 0.27 M NaCl, 0.2% Triton X-100, and 0.07 M Tris-HCl
buffer, pH 7.4, as described earlier (26). The supernatant of the
homogenate was stored at 4 °C, and the Triton-insoluble pellet was
dissolved in 1% SDS at room temperature for 2 h, after which the
insoluble remains were discarded. Alternatively, the cells were
suspended and homogenized in 0.75 M NaCl, 0.5 M acetic acid, pH 2, on ice (7.5 × 106 cells/ml) for
30 s using a glass-Teflon homogenizer. The homogenate was
centrifuged at 12,000 × g for 20 min at 4 °C, and
proteins were precipitated from the supernatant by increasing the NaCl concentration to 3 M and mixing at 4 °C for 12-16 h
followed by centrifugation and dissolving of the pellet in 50 mM acetic acid (27). Homogenization was performed either
without protease inhibitors or in the presence of 10 mM
EDTA, 1 mM phenylmethylsulfonyl fluoride, 10 µM E-64, 1 µM leupeptin, 1 µM
pepstatin, and 75 nM aprotinin, separately or in various combinations.
Purification of Recombinant Protein from Culture Medium--
The
presence of type IX collagen in the culture medium was assayed by
dialyzing the medium against 50 mM acetic acid followed by
SDS-PAGE1 and Western
blotting with the monoclonal antibody
95D1A.2 To purify the type IX
collagen, the proteins were precipitated from the culture medium by
adding solid ammonium sulfate to a 25% saturation and placing the
mixture on ice for 1 h. The precipitate was collected by
centrifugation at 12,000 × g for 20 min at 4 °C and
dissolved in 0.5 M urea, 0.2 M NaCl, and 0.05 M Tris-HCl buffer, pH 7.4, at 4 °C overnight to a
concentration of about 1 mg/ml. The dissolved recombinant protein was
then purified by gel filtration through Sephacryl S-300HR in the same
buffer. Further purification was achieved by cation exchange on a
CM-Sepharose fast flow column in a buffer of 2 M urea, 50 mM PIPES, and 20 mM NaCl at pH 6.5, eluting
with an increasing NaCl concentration gradient (0.02-1 M NaCl).
Characterization of Recombinant Type IX Collagen--
The
recombinant protein isolated was characterized by SDS-PAGE followed by
staining with Coomassie Brilliant Blue or Western blotting with the
monoclonal antibody 95D1A. The purified material was dialyzed against
50 mM acetic acid, hydrolyzed in 6 M HCl at
110 °C for 16 h and subjected to amino acid analysis in an Applied Biosystems 421 analyzer. The thermal stability of the material
was determined by CD analysis at a fixed wavelength (221 nm), raising
the temperature linearly at a rate of 60 °C/h (28). For N-terminal
sequencing, purified recombinant type IX collagen was electrophoresed
under reducing conditions and transferred to ProBlott polyvinylidene
difluoride-type membrane, and the excised bands were subjected to Edman
degradation with 477/120A liquid-phase protein/peptide sequencer
(Applied Biosystems).
Expression of Recombinant Human Type IX Collagen in Insect
Cells--
Three recombinant viruses, each coding for one of the three
Purification of Type IX Collagen from the Culture Medium--
The
presence of type IX collagen in the culture medium was shown by
SDS-PAGE and Western blotting of dialyzed medium using the 95D1A
antibody (Fig. 1). In comparison with the
intracellular material extracted by acid/NaCl and precipitated with 3 M NaCl, the recombinant type IX collagen present in the
medium appeared to be less seriously degraded (Fig. 1), and therefore a
protocol for isolating and purifying type IX collagen from the culture medium was designed. Addition of solid ammonium sulfate to a 25% saturation resulted in specific precipitation of the type IX collagen (Fig. 2), and analysis of the supernatant
from this precipitation by SDS-PAGE followed by Coomassie staining or
Western blotting showed that only a minor amount of type IX collagen
had remained in solution (results not shown). Up to 10 mg of type IX
collagen was obtained from 1 liter of culture medium. The precipitated type IX collagen was dissolved in a buffer containing 0.5 M
urea to enhance the solubilization of the protein, and the solution was
chromatographed on a Sephacryl S-300HR column in the same buffer.
Analysis of the fractions containing most of the type IX collagen
indicated removal of low molecular weight contaminants, e.g.
the remaining bovine serum albumin (Fig.
3, lane 3). Further purification was achieved by cation exchange chromatography on a
CM-Sepharose fast flow column (Fig. 3, lane 4).
Analysis of the Purified Recombinant Human Type IX
Collagen--
The results of amino acid analysis of the purified
material corresponded well with calculated values for human type IX
collagen (Table I), and using these
values, a purity of over 90% was estimated for the recombinant type IX
collagen. The melting behavior of the recombinant type IX collagen was
analyzed by CD. The profile was biphasic, with about
The amino acid sequence at the N terminus of the Association of As type IX collagen is a minor cartilage component that is
covalently cross-linked to type II collagen fibrils and has
interruptions in its triple helix, it has been difficult to isolate
intact type IX collagen molecules from tissues. We have now produced
and isolated intact heterotrimeric human type IX collagen for the first
time using a baculovirus expression system. To obtain stable type IX collagen, a double promoter virus for the Our initial attempts to purify intracellular type IX collagen failed
because the protein was insoluble in a buffer containing Triton X-100
and was easily degraded after acid extraction and selective salt
precipitation. Unlike the intracellular material, type IX collagen
purified from the medium migrated as a single band of over 200 kDa in
SDS-PAGE under nonreducing conditions, and reduction indicated that the
material consisted of three Amino acid analysis of the secreted trimeric type IX collagen showed
that the composition of the material was in agreement with composition
expected based on the cDNA deduced amino acid sequence. An adequate
degree of 4-hydroxylation of the Y-position prolines in the
Gly-X-Y sequences is required to stabilize the collagen
triple helix (31), but the extent of prolyl 4-hydroxylation in type IX
collagen is currently not known. That in the recombinant type IX
collagen was about 80% of the theoretical maximum. CD analysis
indicated that this degree of hydroxylation is adequate, because the
Tm values of the recombinant type IX collagen
corresponded well to the values reported for type IX collagen isolated
from tissues (32). The transition profile was biphasic because the COL3
domain has a higher thermal stability than the rest of the molecule
(32). The results of CD analysis also indicate proper folding of the
recombinant type IX collagen.
The results presented here show that all recombinant type IX collagen
In a reassociation study using pepsin-resistant C-terminal low
molecular weight fragments of bovine type IX collagen, Labourdette and
van der Rest (14) found some formation of homomeric molecules in
addition to the expected Two cysteine residues located at the COL1/NC1 junction in all three
We thank Helena Lindqvist for expert technical assistance.
*
This work was supported in part by the European Community
project BIO-4-CT96-0537 (to L. A.-K. and R. T.) and grants from the
Academy of Finland (to L. A.-K. and M. P.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
2
This antibody was generated using a collagenous
fragment of recombinant human type XIII collagen as an antigen. It was
found to recognize the collagen domains of various denatured collagen chains (A. Snellman and T. Pihlajaniemi, unpublished observations).
The abbreviations used are:
PAGE, polyacrylamide
gel electrophoresis;
Tm, midpoint temperature of
thermal transition;
PIPES, 1,4-piperazinediethanesulfonic acid.
Characterization of Recombinant Human Type IX Collagen
ASSOCIATION OF
CHAINS INTO HOMOTRIMERIC AND HETEROTRIMERIC
MOLECULES*
,
§,
,
,
,
, and

Collagen Research Unit, Biocenter and
Department of Medical Biochemistry, University of Oulu,
Kajaanintie 52A, FIN-90220 Oulu, Finland, the § Department
of Medical Biochemistry and Molecular Biology, University of Turku,
20520 Turku, Finland, ¶ FibroGen Inc.,
South San Francisco, California 94080, the
Department of
Biophysical Chemistry, Biozentrum of the University,
CH 4056 Basel, Switzerland, and the ** Max-Planck-Institut für
Biochemie, D-8033 Martinsried, Federal Republic of Germany
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
1(IX),
2(IX), and
3(IX) collagen chains
together with a double promoter virus for the
and
subunits of
human prolyl 4-hydroxylase. Correctly folded recombinant type IX
collagen was secreted, consisting of the three
chains in a 1:1:1
ratio and showing the expected biphasic thermal melting profile.
When the individual
chains were expressed, disulfide-bonded
homotrimers and homodimers of the
chains were observed. When the
cells were coinfected with the viruses for all three
chains,
heterotrimers of
1(IX),
2(IX), and
3(IX) were detected in cell
culture medium, and the other possible combinations were less
prominent. When any two of the
chains were co-expressed, in
addition to the homodimers and homotrimers, only
1(IX) and
3(IX)
chains were disulfide-bonded. The results thus suggest that the most
favored molecular species is an
1(IX)
2(IX)
3(IX) heterotrimer,
but the chains are also able to form disulfide-bonded heterotrimers of
1(IX) and
3(IX) chains and (
1(IX))3,
(
2(IX))3, and (
3(IX))3 homotrimers.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
1(IX),
2(IX), and
3(IX) (1) and possesses three collagenous
domains (COL1 to COL3, numbered from the C terminus) flanked by four
noncollagenous domains (NC1 to NC4) (2, 3). Type IX collagen is also a
proteoglycan, because a glycosaminoglycan side chain is covalently
attached to the NC3 domain of the
2(IX) chain (4).
3(IX) chain and the C-telopeptide of type
II collagen and between the N-terminal ends of the COL2 domains of all
the type IX collagen
chains and the N-telopeptide of type II
collagen stabilize the interaction between type II and IX collagens
(5-8). The flexibility of the NC3 domain of type IX collagen allows
the COL3 and NC4 domains to project from the fibril surface, possibly
to mediate interactions between cartilage collagens and noncollagenous
proteins (6, 9, 10).
chains in proper stoichiometry and register is a
prerequisite for the formation of a stable collagen helix. The
mechanism of chain selection and association has been studied most
extensively in the fibrillar collagens, for which the crucial role of
large C-terminal propeptides in chain selection and association has
been demonstrated. These propeptides contain specific recognition
sequences that direct the association of
chains in a collagen
type-specific manner (11, 12). For example, the fibrillar collagenous
polypeptides synthesized by chondrocytes, namely
1(II),
1(XI),
and
2(XI), are found only as two trimeric molecules in
vivo, (
1(II))3 and
1(XI)
2(XI)
1(II), despite the 10 theoretically possible combinations (13).
1(IX) and
2(IX) chains, although the heterotrimer
1
2
3 was the predominant
molecule formed when all three chains were present. Similar results
were obtained using synthetic peptides containing the complete NC1 domains and five C-terminal Gly-X-Y tripeptide units of the
COL1 domain (16). These peptides were able to associate into trimers stabilized by disulfide bonds, thus indicating a significant role of
the NC1 domain in chain selection and association. Interestingly, generation of a mouse line harboring an inactivated Col9a1
gene (17) led to a functional knockout of all type IX collagen
polypeptides, suggesting that homotrimers or heterotrimers of the
2(IX) and
3(IX) chains do not exist in vivo without
the
1(IX) chain (18).
chains, in insect cells simultaneously
with the tetrameric enzyme prolyl 4-hydroxylase, needed for the
production of stable collagen.
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
Chains and Generation of the Recombinant Viruses--
Total RNA was
extracted from human fetal cartilage of several individuals by the
guanidium isothiocyanate method, and about 1 µg of total RNA was
reverse-transcribed using an oligo(dT) primer and Moloney murine
leukemia virus reverse transcriptase (Life Technologies, Inc.).
Aliquots of cDNA were used for a single step amplification by
polymerase chain reaction (ExpandTM long template
polymerase chain reaction system; Roche Molecular Biochemicals) using
oligonucleotide primers for the 5'- and 3'-ends of the three
chains. Specific oligonucleotide primers for the
1(IX) chain were
designed based on the published sequences (19, 20). The oligonucleotide
MH-18 (ACT CCC TTG CGG CCG CTT CTT CAT AGG), corresponding to the
5'-noncoding sequence of the
1(IX) cDNA, contained an engineered
NotI cleavage site, and the oligonucleotide MH-19 (TCA TGC
AGA CGG CCG TGC AGC AGT AAG), corresponding to the 3'-noncoding
sequence, contained an engineered EagI cleavage site. For
amplification of the
2(IX) cDNA, the specific oligonucleotides MH-22 (TCT GCC GTC GGT GCG GCC GCG GAC ACG C), corresponding to the
5'-noncoding sequence of the
2(IX) cDNA, and MH-23 (TCA TGC AGA
CGG CCG TGC AGC AGT AAG), corresponding to the 3'-noncoding sequence,
were designed based on published sequences (21, 22). The
oligonucleotide MH-22 contained an engineered NotI cleavage site, and MH-23 contained an engineered EagI cleavage site.
Specific oligonucleotides for the 5'- and 3'-ends of the
3(IX)
cDNA were designed based on the published sequences (23). The
oligonucleotides MH-29 (CCC GAC GCC GCA GTC TAG ACT CCG CCA CGC),
corresponding to the 5'-noncoding sequence of the
3(IX) cDNA,
and MH-30 (TCG GGC GTC CTT GTC TCT AGA TTC CTC ACG), corresponding to
the 3'-noncoding sequence, contained engineered XbaI
cleavage sites. The cDNAs were digested with the enzymes indicated
above and ligated into the pVL1392 vector. The cDNAs were
completely sequenced (SequenaseTM reagent kit, Amersham
Pharmacia Biotech) using cDNA-specific sequencing primers. The
three recombinant constructs were co-transfected into Spodoptera
frugiperda (Sf9; Invitrogen) insect cells with a modified
Autographa californica nuclear polyhedrosis virus by means
of the BaculoGold transfection kit (Pharmingen), and the resultant
viral pools were collected, amplified, and plaque-purified (24).
1(IX),
2(IX), and
3(IX) chains and a double promoter virus
4PH
coding for the
- and
-subunits of human prolyl
4-hydroxylase (25), with multiplicities of infection of 2:2:2:4,
respectively. Ascorbate (80 µg/ml) was added daily to the culture medium.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
chains of human type IX collagen, were generated and used to infect
High Five cells together with a double promoter virus, 4PH
(25),
coding for the
and
subunits of human prolyl 4-hydroxylase. The
cells were harvested after 72 h of culture and homogenized in a
buffer containing Triton X-100, as used to isolate other recombinant
collagens from insect cells (26, 29) and to extract type IX collagen
from tissues. No recombinant protein could be detected in the Triton
X-100 soluble protein fraction by Coomassie staining, but individual
chains were clearly detectable in the insoluble fraction (not
shown). Selective salt precipitation, which had been used previously to
extract type IX collagen from tissues (27), was therefore used to
isolate intracellular type IX collagen. The amount of intracellular
type IX collagen produced by the insect cells was estimated by
comparison with known amounts of Coomassie-stained recombinant human
type II collagen to be 4-8 mg/liter of culture (not shown). However,
analyses of the isolated material by Western blotting with the 95D1A
antibody repeatedly revealed that the material was partially degraded, an effect that was not significantly reduced by the use of various protease inhibitors (not shown).

View larger version (42K):
[in a new window]
Fig. 1.
Comparison of the intracellular and secreted
recombinant human type IX collagen by SDS-PAGE and Western
blotting. After 72 h of coinfection of High Five cells with
the recombinant baculoviruses for the
1(IX),
2(IX), and
3(IX)
chains and the 4PH
virus, intracellular type IX collagen was
extracted from the cells in 0.75 M NaCl/0.5 M
acetic acid and precipitated in 3 M NaCl in the presence of
protease inhibitors. The culture medium from the expression was
dialyzed against acetic acid and analyzed for the presence of
extracellular type IX collagen. Samples were electrophoresed by 8%
SDS-PAGE under reducing conditions and analyzed by Western blotting
with a monoclonal antibody recognizing collagenous structures.
Lane 1, molecular weight markers; lane
2, intracellular type IX collagen; lane
3, extracellular type IX collagen.

View larger version (58K):
[in a new window]
Fig. 2.
Efficiency of ammonium sulfate in selective
precipitation of secreted recombinant type IX collagen. After
72 h of coinfection of High Five cells with the recombinant
baculoviruses for the
1(IX),
2(IX), and
3(IX) chains and the
4PH
virus, the culture medium was clarified by centrifugation,
and solid ammonium sulfate was added to achieve the concentrations
indicated (percentage of saturation). After 1 h, the precipitates
were collected by centrifugation, dissolved, subjected to 10% SDS-PAGE
under reducing conditions, and analyzed by Coomassie staining.
Lane 1, molecular weight markers;
lanes 2-6, extracellular material precipitated
in the concentrations of ammonium sulfate indicated (calculated as
saturation percentages).

View larger version (37K):
[in a new window]
Fig. 3.
Analysis of the efficiency of gel filtration
and cation exchange in the purification of recombinant human type IX
collagen. Type IX collagen was precipitated from the culture
medium by adding ammonium sulfate to 25% saturation, and the
precipitate was collected, dissolved (lane 2),
and subjected to chromatography on a Sephacryl S-300HR gel filtration
column (lane 3), followed by cation exchange on a
CM-Sepharose fast flow column (lane 4). Samples
of the unpurified ammonium sulfate precipitate and the chromatographed
material were subjected to 5% SDS-PAGE under nonreducing conditions in
A and to 10% SDS-PAGE under reducing conditions in
B, followed by Coomassie staining. Lane
1, molecular weight markers.
of the
transition centering at Tm = 37.5 °C and
about
of the transition centering at
Tm = 46.0 °C (Fig.
4).
Amino acid analysis of the purified recombinant human type IX collagen

View larger version (17K):
[in a new window]
Fig. 4.
CD analysis of denaturation of the purified
recombinant type IX collagen. Denaturation was monitored by the
change of mean molar ellipticity in 0.05 M acetic acid at a
fixed wavelength (221 nm). The estimated Tm
values were 37.5 °C (about
of transition) and 46.0 °C
(about
of transition).
1(IX) chain, as
identified by Edman degradation, was AVKRRPR, corresponding to the
predicted signal peptide cleavage site (19). The sequences for the
2(IX) and
3(IX) chains could not be determined, apparently because of N-terminal blocking. The tendency of the N termini of these
two chains to get blocked may be explained by possible presence of
glutamine (22, 23) at the N terminus of the polypeptides (30).
Chains into Disulfide-bonded Molecules--
The
formation of disulfide-bonded homomeric and heteromeric molecules by
the
chains was studied by expressing each chain individually and in
all possible combinations together with prolyl 4-hydroxylase. Analyses
of samples of the culture media by SDS-PAGE followed by Western
blotting with the 95D1A antibody showed that all three
chains of
human type IX collagen appear to be capable of forming disulfide-bonded
homodimers. Whereas
1(IX) chains showed clear homotrimer formation,
the homotrimers of
2(IX) and
3(IX) chains were not readily
detectable (Fig. 5). When all three chains are expressed simultaneously, the heterotrimer
1(IX)
2(IX)
3(IX) is the dominant molecular species. However, it
is possible that also other disulfide-bonded trimers are formed, but in
quantities that are below the detection limit. Interestingly,
co-expression of any two
chains results in formation of detectable
amounts of disulfide-bonded heterodimeric molecules only when the
chains concerned are
1(IX) and
3(IX) (Fig. 5). Any other
combination of two
chains appears to result only in the formation
of disulfide-bonded homodimers (Fig. 5). Abundance of monomeric
molecules seen in Fig. 5 is likely to reflect the release of the
monomers into the culture medium due to cell lysis during the
expression. Second, some of the monomers may originate from secreted
trimeric molecules that were not fully disulfide-bonded. Also, the
abundance of monomers is in part an artifact, because the efficiency of
electroblotting is inversely related to the size of the blotted
molecules.

View larger version (41K):
[in a new window]
Fig. 5.
Analysis of type IX collagen chain
association. The recombinant
chains were expressed
individually and in all possible combinations together with prolyl
4-hydroxylase in an adherent culture of High Five cells. Samples of the
culture media were analyzed by SDS-PAGE under nonreducing conditions
and Western blotting with the antibody 95D1A. Molecular species were
identified by differences in electrophoretic mobility. Lane
1, prolyl 4-hydroxylase expressed alone; lane 2,
1(IX); lane 3,
2(IX); lane 4,
3(IX);
lane 5,
1(IX) and
2(IX); lane 6,
1(IX)
and
3(IX); lane 7,
2(IX) and
3(IX); lane
8, all three
chains co-expressed.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
and
subunits of prolyl 4-hydroxylase (25) was co-expressed with three viruses for the
chains of type IX collagen itself.
chains in a 1:1:1 ratio. It is likely
that the three viruses for the
chains and the virus for prolyl
4-hydroxylase do not infect all the insect cells with equal efficiency,
which in turn may lead to the intracellular accumulation of
underhydroxylated and improperly folded molecules that are insoluble or
susceptible to degradation.
chains are able to form disulfide-bonded homodimers, whereas only
the
1(IX) chains show homotrimer formation. These findings support
previous observations that the C-terminal fragments of
1(IX) chains
exhibit the highest potential for homotrimer formation and
3(IX)
chains have the lowest ability for self-association (16). Monomers and
disulfide-bonded dimeric molecules were also detected in the culture
medium. Because collagens are secreted as trimeric molecules, these
species may originate from secreted trimeric molecules that were not
fully disulfide-bonded. Alternatively, the monomers and dimers could
represent immature molecules that are released into the culture medium
as a result of cell lysis.
1
2
3 heterotrimer upon mixing of fragments of all three
chains. Our results obtained using
full-length
chains indicate that the heterotrimer is the
predominant product formed. It is therefore possible that the C termini
of the NC1 domains that are missing in the low molecular weight
fragments enhance formation of the heterotrimer in preference to
homotrimers. Because our results were obtained using secreted material,
it is possible that homotrimeric molecules are also formed but remain mostly intracellular. It is also possible that homotrimeric molecules are present in the culture medium, but in very low quantities.
(IX) chains are involved in interchain disulfide bond formation. The
functionality of these cysteines in connecting together any two of the
chains has been demonstrated by Labourdette and van der Rest (14),
who were able to detect all possible dimeric combinations in minor
quantities. In the present case, however,
1
3 was the only
heterodimeric molecular structure detected. It is possible that the
other two disulfide-bonded heterodimeric species were also formed but
in quantities that were below the detection limit of the experimental
system. Similarly, it is possible that in a reassociation study using
synthetic NC1 domains (16), heterodimeric molecules were formed but
remained undetected. Even though our results were obtained with a
semiquantitative analysis, it appears that co-expression of the
1(IX) and
3(IX) chains results in formation of the heterodimer,
which dominates the respective homodimers. The results thus suggest
that in the association of full-length type IX collagen
chains the
most favored trimeric form is an
1(IX)
2(IX)
3(IX) heterotrimer,
although
1(IX) chains are capable of forming disulfide-bonded
homotrimeric molecules.
![]()
ACKNOWLEDGEMENT
![]()
FOOTNOTES

To whom correspondence should be addressed. Tel.:
358-8-5375756; Fax: 358-8-5375811; E-mail:
Leena.Ala-Kokko@oulu.fi.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
1.
van der Rest, M.,
and Mayne, R.
(1987)
in
Structure and Function of Collagen Types
(Mayne, R.
, and Burgeson, R. E., eds)
, pp. 195-221, Academic Press, Orlando, FL
2.
Ninomiya, Y.,
Castagnola, P.,
Gerecke, D.,
Gordon, M. K.,
Jacenko, O.,
LuValle, P.,
McCarthy, M.,
Muragaki, Y.,
Nishimura, I.,
Oh, S.,
Rosenblum, N.,
Sato, N.,
Sugrue, S.,
Taylor, R.,
Vasios, G.,
Yamaguchi, N.,
and Olsen, B. R.
(1990)
in
Extracellular matrix genes
(Sandell, L. J.
, and Boyd, C. D., eds)
, pp. 79-114, Academic Press, San Diego, CA
3.
Brewton, R. G.,
and Mayne, R.
(1994)
in
Extracellular Matrix Assembly and Structure
(Yurchenco, P. D.
, Birk, D. E.
, and Mecham, R. P., eds)
, pp. 129-170, Academic Press, San Diego, CA
4.
Bruckner, P.,
Vaughan, L.,
and Winterhalter, K. H.
(1985)
Proc. Natl. Acad. Sci. U. S. A.
82,
2608-2612 5.
Eyre, D. R.,
Apon, S.,
Wu, J. J.,
Ericsson, L. H.,
and Walsh, K. A.
(1987)
FEBS Lett.
220,
337-341[CrossRef][Medline]
[Order article via Infotrieve]
6.
van der Rest, M.,
and Mayne, R.
(1988)
J. Biol. Chem.
263,
1615-1618 7.
Wu, J. J.,
Woods, P. E.,
and Eyre, D. R.
(1992)
J. Biol. Chem.
267,
23007-23014 8.
Diab, M.,
Wu, J. J.,
and Eyre, D.
(1996)
Biochem. J.
314,
327-332
9.
Vasios, G.,
Nishimura, I.,
Konomi, H.,
van der Rest, M.,
Ninomiya, Y.,
and Olsen, B. R.
(1988)
J. Biol. Chem.
263,
2324-2329 10.
Vaughan, L.,
Mendler, M.,
Huber, S.,
Bruckner, P.,
Winterhalter, K. H.,
Irwin, M. H.,
and Mayne, R.
(1988)
J. Cell Biol.
106,
991-997 11.
Lees, J. F.,
Tasab, M.,
and Bulleid, N. J.
(1997)
EMBO J.
16,
908-916[CrossRef][Medline]
[Order article via Infotrieve]
12.
Bulleid, N. J.,
Dalley, J. A.,
and Lees, J. F.
(1997)
EMBO J.
16,
6694-6701[CrossRef][Medline]
[Order article via Infotrieve]
13.
Morris, M. P.,
and Bächinger, H. P.
(1987)
J. Biol. Chem.
262,
11345-11350 14.
Labourdette, L.,
and van der Rest, M.
(1993)
FEBS Lett.
320,
211-214[CrossRef][Medline]
[Order article via Infotrieve]
15.
Reese, C. A.,
and Mayne, R.
(1981)
Biochemistry
20,
5443-5448[CrossRef][Medline]
[Order article via Infotrieve]
16.
Mechling, D. E.,
Gambee, J. E.,
Morris, N. P.,
Sakai, L. Y.,
Keene, D. R.,
Mayne, R.,
and Bächinger, H. P.
(1996)
J. Biol. Chem.
271,
13781-13785 17.
Fässler, R.,
Schnegelsberg, P. N. J.,
Dausman, J.,
Shinya, T.,
Muragaki, Y.,
McCarthy, M. T.,
Olsen, B. R.,
and Jaenisch, R.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
5070-5074 18.
Hagg, R.,
Hedbom, E.,
Möllers, U.,
Aszódi, A.,
Fässler, R.,
and Bruckner, P.
(1997)
J. Biol. Chem.
272,
20650-20654 19.
Muragaki, Y.,
Kimura, T.,
Ninomiya, Y.,
and Olsen, B. R.
(1990)
Eur. J. Biochem.
192,
703-708[Medline]
[Order article via Infotrieve]
20.
Rokos, I.,
Muragaki, Y.,
Warman, M.,
and Olsen, B. R.
(1994)
Matrix Biol.
14,
1-8[CrossRef][Medline]
[Order article via Infotrieve]
21.
Perälä, M.,
Hänninen, M.,
Hästbacka, J.,
Elima, K.,
and Vuorio, E.
(1993)
FEBS Lett.
319,
177-180[CrossRef][Medline]
[Order article via Infotrieve]
22.
Pihlajamaa, T.,
Vuoristo, M. M.,
Annunen, S.,
Perälä, M.,
Prockop, D. J.,
and Ala-Kokko, L.
(1998)
Matrix Biol.
17,
237-241[CrossRef][Medline]
[Order article via Infotrieve]
23.
Brewton, R. G.,
Wood, B. M.,
Ren, Z.-X.,
Gong, Y.,
Tiller, G. E.,
Warman, M. L.,
Lee, B.,
Horton, W. A.,
Olsen, B. R.,
Baker, J. R.,
and Mayne, R.
(1995)
Genomics
30,
329-336[CrossRef][Medline]
[Order article via Infotrieve]
24.
Gruenwald, S.,
and Heitz, J.
(1993)
Baculovirus Expression Vector System: Procedures and Methods Manual
, pp. 51-52, Pharmingen, San Diego, CA
25.
Nokelainen, M.,
Helaakoski, T.,
Myllyharju, J.,
Notbohm, H.,
Pihlajaniemi, T.,
Fietzek, P. P.,
and Kivirikko, K. I.
(1998)
Matrix Biol.
16,
329-338[CrossRef][Medline]
[Order article via Infotrieve]
26.
Lamberg, A.,
Helaakoski, T.,
Myllyharju, J.,
Peltonen, S.,
Notbohm, H.,
Pihlajaniemi, T.,
and Kivirikko, K. I.
(1996)
J. Biol. Chem.
271,
11988-11995 27.
Duance, V. C.,
Wotton, S. F.,
Voyle, C. A.,
and Bailey, A. J.
(1984)
Biochem. J.
221,
885-889[Medline]
[Order article via Infotrieve]
28.
Gaill, F.,
Wiedemann, H.,
Mann, K.,
Kühn, K.,
Timpl, R.,
and Engel, J.
(1991)
J. Mol. Biol.
221,
209-223[CrossRef][Medline]
[Order article via Infotrieve]
29.
Myllyharju, J.,
Lamberg, A.,
Notbohm, H.,
Fietzek, P. P.,
Pihlajaniemi, T.,
and Kivirikko, K. I.
(1997)
J. Biol. Chem.
272,
21824-21830 30.
Blombäck, B.
(1967)
Methods Enzymol.
11,
398-411
31.
Prockop, D. J.,
and Kivirikko, K. I.
(1995)
Annu. Rev. Biochem.
64,
403-434[CrossRef][Medline]
[Order article via Infotrieve]
32.
Miles, C. A.,
Knott, L.,
Sumner, I. G.,
and Bailey, A. J.
(1998)
J. Mol. Biol.
277,
135-144[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. Fresquet, T. A. Jowitt, J. Ylostalo, P. Coffey, R. S. Meadows, L. Ala-Kokko, D. J. Thornton, and M. D. Briggs Structural and Functional Characterization of Recombinant Matrilin-3 A-domain and Implications for Human Genetic Bone Diseases J. Biol. Chem., November 30, 2007; 282(48): 34634 - 34643. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Budde, K. Blumbach, J. Ylostalo, F. Zaucke, H. W. A. Ehlen, R. Wagener, L. Ala-Kokko, M. Paulsson, P. Bruckner, and S. Grassel Altered Integration of Matrilin-3 into Cartilage Extracellular Matrix in the Absence of Collagen IX Mol. Cell. Biol., December 1, 2005; 25(23): 10465 - 10478. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kapyla, J. Jaalinoja, M. Tulla, J. Ylostalo, L. Nissinen, T. Viitasalo, P. Vehvilainen, V. Marjomaki, P. Nykvist, A.-M. Saamanen, et al. The Fibril-associated Collagen IX Provides a Novel Mechanism for Cell Adhesion to Cartilaginous Matrix J. Biol. Chem., December 3, 2004; 279(49): 51677 - 51687. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Pihlajamaa, H. Lankinen, J. Ylostalo, L. Valmu, J. Jaalinoja, F. Zaucke, L. Spitznagel, S. Gosling, A. Puustinen, M. Morgelin, et al. Characterization of Recombinant Amino-terminal NC4 Domain of Human Collagen IX: INTERACTION WITH GLYCOSAMINOGLYCANS AND CARTILAGE OLIGOMERIC MATRIX PROTEIN J. Biol. Chem., June 4, 2004; 279(23): 24265 - 24273. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Karppinen, E. Paakko, P. Paassilta, J. Lohiniva, M. Kurunlahti, O. Tervonen, P. Nieminen, H. H. H. Goring, A. Malmivaara, H. Vanharanta, et al. Radiologic Phenotypes in Lumbar MR Imaging for a Gene Defect in the COL9A3 Gene of Type IX Collagen Radiology, April 1, 2003; 227(1): 143 - 148. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Paassilta, J. Lohiniva, H. H. H. Goring, M. Perala, S. S. Raina, J. Karppinen, M. Hakala, T. Palm, H. Kroger, I. Kaitila, et al. Identification of a Novel Common Genetic Risk Factor for Lumbar Disk Disease JAMA, April 11, 2001; 285(14): 1843 - 1849. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Snellman, M.-R. Keranen, P. O. Hagg, A. Lamberg, J. K. Hiltunen, K. I. Kivirikko, and T. Pihlajaniemi Type XIII Collagen Forms Homotrimers with Three Triple Helical Collagenous Domains and Its Association into Disulfide-bonded Trimers Is Enhanced by Prolyl 4-Hydroxylase J. Biol. Chem., March 17, 2000; 275(12): 8936 - 8944. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Paassilta, T. Pihlajamaa, S. Annunen, R. G. Brewton, B. M. Wood, C. C. Johnson, J. Liu, Y. Gong, M. L. Warman, D. J. Prockop, et al. Complete Sequence of the 23-Kilobase Human COL9A3 Gene. DETECTION OF GLY-X-Y TRIPLET DELETIONS THAT REPRESENT NEUTRAL VARIANTS J. Biol. Chem., August 6, 1999; 274(32): 22469 - 22475. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Thur, K. Rosenberg, D. P. Nitsche, T. Pihlajamaa, L. Ala-Kokko, D. Heinegard, M. Paulsson, and P. Maurer Mutations in Cartilage Oligomeric Matrix Protein Causing Pseudoachondroplasia and Multiple Epiphyseal Dysplasia Affect Binding of Calcium and Collagen I, II, and IX J. Biol. Chem., February 23, 2001; 276(9): 6083 - 6092. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||